Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis.

Intern Med · 2021 · PMC8188012 · PMID 33361677

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

As blood ammonia concentrations did not show an increasing trend over the course of six months following the switch to rifaximin, rifaximin appeared to be at least as effective as (if not more than) kanamycin sulfate.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.